Roivant Sciences Investor
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Investors
Technology:
Biopharma, Biotechnology, Health Care, Pharmaceutical, Product Research
Industry:
Clinical Development, Preclinical Development
Headquarters:
New York, New York, United States
Founded Date:
2014-05-01
Employees Number:
501-1000
Funding Status:
IPO
Number Of Exits:
2
Acquisitions Number:
2
Investors Number:
15
Total Funding:
2093000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-10-01
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership